G
Giuseppe Mancia
Researcher at University of Milano-Bicocca
Publications - 1465
Citations - 152794
Giuseppe Mancia is an academic researcher from University of Milano-Bicocca. The author has contributed to research in topics: Blood pressure & Ambulatory blood pressure. The author has an hindex of 145, co-authored 1369 publications receiving 139692 citations. Previous affiliations of Giuseppe Mancia include University of Milan & Instituto Politécnico Nacional.
Papers
More filters
Journal ArticleDOI
Efficacy and tolerability profile of nebivolol vs atenolol in mild-to-moderate essential hypertension: results of a double-blind randomized multicentre trial
Guido Grassi,Fosca Quarti Trevano,A. Facchini,Torakis Toutouzas,Bernard Chanu,Giuseppe Mancia +5 more
TL;DR: Evidence is provided, that, for the same antihypertensive effects, nebivolol shows a better tolerability profile than atenolol and a lower incidence of adverse effects.
Journal ArticleDOI
Longing for clinical excellence: a critical outlook into the NICE recommendations on hypertension management – is nice always good?
TL;DR: The authors have focused on the new edition of the UK NICE guidelines to learn about the difficulties of disentangling evidence from wisdom when preparing recommendations.
Journal ArticleDOI
Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus: The ADVANCE-ON Study.
Toshiaki Ohkuma,Mark Woodward,Mark Woodward,Mark Woodward,Min Jun,Paul Muntner,Jun Hata,Stephen Colagiuri,Stephen B. Harrap,Giuseppe Mancia,Neil Poulter,Bryan Williams,Peter M. Rothwell,John Chalmers +13 more
TL;DR: In this article, the authors used the ADVANCE-ON (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation) randomized controlled trial in patients with type 2 diabetes mellitus.
Journal ArticleDOI
Efficacy and safety of routine blood pressure lowering in older patients with diabetes: Results from the advance trial
Toshiharu Ninomiya,Sophia Zoungas,Sophia Zoungas,Bruce Neal,Mark Woodward,Mark Woodward,Anushka Patel,Vlado Perkovic,Alan Cass,Mark E. Cooper,Diederick E. Grobbee,Pavel Hamet,Stephen B. Harrap,Lisheng Liu,Giuseppe Mancia,Carl Erik Mogensen,Neil R Poulter,Anthony Rodgers,Bryan Williams,Stephen MacMahon,John Chalmers +20 more
TL;DR: Routine administration of perindopril–indapamide lowers blood pressure safely and reduces the risk of major clinical outcomes in patients of at least 75 years with type 2 diabetes.
Journal ArticleDOI
Progression of functional and structural cardiac alterations in young normotensive uncomplicated patients with type 1 diabetes mellitus
Stefano Carugo,Cristina Giannattasio,I. Calchera,F. Paleari,Maria Grazia Gorgoglione,Alessandra Grappiolo,Pierluigi Gamba,Giovanni Rovaris,Monica Failla,Giuseppe Mancia +9 more
TL;DR: Uncomplicated type I diabetes mellitus is characterized by early structural and functional cardiac alterations, and some of these alterations show a measurable progression within a relatively short time span.